U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185321) titled 'A Phase 1 Study of Mosliciguat in Healthy, Adult Males' on Sept. 12.
Brief Summary: This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.
Study Start Date: June 10
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Mosliciguat
Dose level for inhalation
DRUG: 14C mosliciguat
Dose level
DEVICE: Dry Powder Inhaler
Dry powder inhaler for mosliciguat
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Pulmovant, Inc.
Published by HT Digital C...